Uniphar’s (UPR) Buy Rating Reiterated at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft reissued their buy rating on shares of Uniphar (LON:UPR) in a research report sent to investors on Wednesday, Marketbeat Ratings reports. Deutsche Bank Aktiengesellschaft currently has a GBX 310 ($4.08) price objective on the stock.

Uniphar Price Performance

Shares of LON UPR opened at GBX 221 ($2.91) on Wednesday. The company has a quick ratio of 0.60, a current ratio of 0.88 and a debt-to-equity ratio of 114.50. The business’s 50 day moving average price is GBX 217.21 and its two-hundred day moving average price is GBX 222.56. The company has a market cap of £603.37 million, a PE ratio of 1,578.57 and a beta of 0.77. Uniphar has a twelve month low of GBX 178 ($2.34) and a twelve month high of GBX 256 ($3.37).

Uniphar Cuts Dividend

The firm also recently declared a dividend, which will be paid on Friday, October 4th. Investors of record on Thursday, September 12th will be paid a €0.01 ($0.01) dividend. This represents a yield of 0.25%. The ex-dividend date is Thursday, September 12th. Uniphar’s dividend payout ratio (DPR) is presently 1,428.57%.

About Uniphar

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.